Cabozantinib malate

Cabozantinib malate, Cabozantinib S-malate, 1140909-48-3, cabozantinib (S)-malate, Cabometyx, XL184, DR7ST46X58, CHEBI:72319, DTXSID60915949, RefChem:1080604, DTXCID501510465, Cabozantinib malate (XL184), Cabozantinib (S-malate), Cometriq, Cabozantinib L-Malate Salt, MFCD20923480, Cabozantinib s-malate [USAN], C32H30FN3O10, Cabometyx (TN), Cometriq (TN), Cabozantinib malate (JAN), 1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-2-hydroxybutanedioic acid, N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-hydroxysuccinate, Cabozantinib s-malate (USAN), CABOZANTINIB MALATE [JAN], cabozantinib L-malate, UNII-DR7ST46X58, XL184 (S-malate), BMS-907351 (S-malate), RESNIBEN, XL-184 malate, Cabozantinib S-malate?, Cabozantinib S-Malate salt, XL184(Cabozantinib malate), MLS006010951, orb1307421, CHEMBL2103868, SCHEMBL29350740, SCHEMBL29881226, HFCFMRYTXDINDK-WNQIDUERSA-N, GLXC-10543, EX-A2819, EBC-17171, s4001, AKOS025401945, CABOZANTINIB S-MALATE [WHO-DD], CCG-270301, CS-0201, FC64967, AC-27471, AS-75255, HY-12044, SMR004702755, SY105860, CABOZANTINIB S-MALATE [ORANGE BOOK], SW218093-2, D10095, F861544, Q27139901, (2S)-2-Hydroxybutanedioic acid--N~1~-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'~1~-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (1/1), (2S)-2-hydroxybutanedioic acid, N'1-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, 1,1-Cyclopropanedicarboxamide, N'-(4-((6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4- fluorophenyl)- mono((2S)-2-hydroxybutanedioate), Butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7- dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1- cyclopropanedicarboxamide, cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide(4-fluoro-phenyl)-amide, (S) malate salt, inverted exclamation mark N-[4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl]-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-Hydroxysuccinate, N-(4-((6,7-DIMETHOXYQUINOLIN-4-YL)OXY)PHENYL)-N'-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE MONO((2S)-2-HYDROXYBUTANEDIOATE), N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-hydroxysuccinate, N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (2S)-2-hydroxybutanedioate, N1-[4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N1'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-2-hydroxybutanedioic acid